Lv5
1450 积分 2024-01-26 加入
Insights from the AUSTRI study on reliever use before and after asthma exacerbations
1个月前
已完结
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America
1个月前
已完结
Exacerbations of Asthma: A Descriptive Study of 425 Severe Exacerbations
1个月前
已完结
Eosinophils in COPD: just another biomarker?
2个月前
已完结
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study
4个月前
已完结
Anaphylaxis: A 2023 practice parameter update
5个月前
已完结
Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis
5个月前
已完结
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
5个月前
已完结
Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
6个月前
已完结
Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial
6个月前
已完结
皖公网安备34019202002308
